{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":4,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":4,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"a36e830bb1f5","filters":{"venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs"}},"results":[{"id":"W2766000227","doi":"10.2174/2213476x03666160127001910","title":"Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Probiotics and Fermented Foods","field":"Agricultural and Biological Sciences","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Probiotic; Context (archaeology); Good manufacturing practice; Business; Quality (philosophy); Scopus; Product (mathematics); Risk analysis (engineering); Control (management); Marketing; MEDLINE; Computer science; Political science; Supply chain; Biology","authors":[{"name":"Malika Arora","is_ca":false},{"name":"Ashish Baldi","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6378639548133486,"gpt":0.5791816973261519,"spread":0.05868225748719669,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06178904,0.0002813992,0.0009949409,0.00005540324,0.0006528955,0.0002583168,0.0003300235,0.0004982798,0.00005519681],"category_scores_gemma":[0.02408059,0.0001296638,0.0003299573,0.0003038568,0.001155996,0.0001792481,0.000350118,0.001275176,0.00001763128],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006117918,"about_ca_system_score_gemma":0.0002203175,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000008317077,"about_ca_topic_score_gemma":0.00002553458,"domain_scores_codex":[0.9916015,0.003738512,0.002247763,0.001080963,0.0006243659,0.0007069358],"domain_scores_gemma":[0.9541674,0.04325086,0.0005377124,0.000231833,0.0005375782,0.001274646],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002832322,0.002207436,0.001337497,0.00007100452,0.0002603053,0.000003203319,0.0000621361,0.0000133927,0.0007589124,0.02207575,0.01023864,0.9601394],"study_design_scores_gemma":[0.01132223,0.004325407,0.02850539,0.0003409097,0.0005577109,0.000008608768,0.003501396,0.00441015,0.001192498,0.03861034,0.906221,0.001004341],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7428297,0.008337658,0.00186057,0.2034211,0.005427385,0.02336604,0.001140494,0.0007005177,0.01291656],"genre_scores_gemma":[0.993108,0.001383125,0.003355844,0.0003485975,0.001360456,0.0001820064,0.0001345567,0.000007827189,0.0001195475],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9591351,"threshold_uncertainty_score":0.98414,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2804493567","doi":"10.2174/2213476x03666151125220117","title":"Regulations of Cosmetics Across the Globe","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Cosmetics; European union; Legislature; Business; Legislation; Political science; Medicine; Law; International trade","authors":[{"name":"Shivaji Rai","is_ca":false},{"name":"Apeksha Gupta","is_ca":false},{"name":"Vikas Punetha","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.543522808613697,"gpt":0.5977178971760421,"spread":0.05419508856234512,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.09945834,0.0001977154,0.001632019,0.0000890059,0.000312178,0.00002946122,0.0003951191,0.004794363,0.00004968801],"category_scores_gemma":[0.04213009,0.000108824,0.0005659179,0.0006496016,0.007436692,0.00003583011,0.0004800434,0.006379414,0.00005402245],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002714614,"about_ca_system_score_gemma":0.000598742,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006545689,"about_ca_topic_score_gemma":0.0000062884,"domain_scores_codex":[0.9913936,0.003005467,0.003330099,0.0006658193,0.001007973,0.0005970108],"domain_scores_gemma":[0.9736442,0.02282892,0.0006032657,0.001359172,0.0007035447,0.0008609125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01424598,0.003786095,0.02325948,0.0002128667,0.002737228,0.00007636635,0.001246221,0.00002064789,0.0008478694,0.4277765,0.1420557,0.3837351],"study_design_scores_gemma":[0.05033981,0.01004067,0.2069771,0.0007397954,0.001697615,0.0001414812,0.03867611,0.001385961,0.003574731,0.1981255,0.4871925,0.001108825],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9040583,0.003391047,0.0003532998,0.06574102,0.001554245,0.002865593,0.00002853495,0.000168151,0.02183981],"genre_scores_gemma":[0.9928555,0.003835501,0.0008558234,0.0004149417,0.0009988266,0.0000339336,0.000009302144,0.00002611879,0.0009700279],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3826262,"threshold_uncertainty_score":0.9964976,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2757851334","doi":"10.2174/2213476x03666160112001136","title":"Product Life Cycle Management for Pharmaceutical Innovation","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Scrutiny; Commercialization; Product lifecycle; Business; Product (mathematics); New product development; Scope (computer science); Biosimilar; Product life-cycle management; Phase (matter); Competition (biology); Pharmaceutical industry; Marketing; Industrial organization; Computer science","authors":[{"name":"Swagat Tripathy","is_ca":false},{"name":"Vandana Prajapati","is_ca":false},{"name":"Vijayakumar Sengodan Guruswamy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.6685465453233798,"gpt":0.6240170960708625,"spread":0.04452944925251723,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2093348,0.0002684529,0.001239975,0.0003471046,0.0002848834,0.0003368889,0.001182383,0.0003107325,0.00001311704],"category_scores_gemma":[0.05554574,0.0002147679,0.0003643131,0.001449818,0.001039968,0.0003287244,0.001337937,0.001048968,0.00006464851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007212949,"about_ca_system_score_gemma":0.0009019835,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001551207,"about_ca_topic_score_gemma":6.832601e-7,"domain_scores_codex":[0.9851658,0.006679135,0.0039597,0.00169157,0.001716479,0.0007872991],"domain_scores_gemma":[0.9441596,0.05059191,0.0007486613,0.001548751,0.001375199,0.001575902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0008176849,0.0004921483,0.0001833543,0.00005240469,0.0001771891,0.000004893137,0.000028963,0.0003353509,0.00001360859,0.5559732,0.01424936,0.4276718],"study_design_scores_gemma":[0.01292476,0.0009402356,0.01047443,0.00006753461,0.00009514438,0.000004016245,0.0003946816,0.09402849,0.0002133129,0.7364598,0.1437744,0.0006232274],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"methods","genre_gemma":"empirical","genre_scores_codex":[0.1863348,0.001524193,0.7305533,0.03213707,0.007212969,0.01172216,0.00003711969,0.0006828211,0.02979557],"genre_scores_gemma":[0.8809586,0.0003409185,0.1145002,0.0009134996,0.002541933,0.000394493,0.0000165586,0.00003752892,0.000296314],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.6946237,"threshold_uncertainty_score":0.9524098,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2759170843","doi":"10.2174/2213476x03666151221210747","title":"Regulatory Overview of Biosimilars: Current Scenario and Future Opportunities","year":2015,"lang":"en","type":"article","venue":"Applied Clinical Research Clinical Trials and Regulatory Affairs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; Biopharmaceutical; Medicine; Business; Risk analysis (engineering); Biotechnology","authors":[{"name":"Ajmer Singh Grewal","is_ca":false},{"name":"Viney Lather","is_ca":false},{"name":"Shashikant Bhardwaj","is_ca":false},{"name":"Deepti Pandita","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7556914656993441,"gpt":0.5835080839316263,"spread":0.1721833817677177,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.1042319,0.0004181716,0.002818804,0.0002374542,0.0002595281,0.00006096615,0.0005196842,0.001674228,0.0002855321],"category_scores_gemma":[0.01110055,0.0002830826,0.000654605,0.0003647961,0.007297339,0.0001029582,0.0008183306,0.002388492,0.00002834761],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000358916,"about_ca_system_score_gemma":0.000744536,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006341381,"about_ca_topic_score_gemma":0.000006883142,"domain_scores_codex":[0.9820869,0.0110901,0.004253516,0.001216265,0.0004964372,0.0008567729],"domain_scores_gemma":[0.9804465,0.01622585,0.0008533311,0.001036119,0.0006074911,0.0008307131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002923941,0.001135767,0.004577055,0.0002872175,0.0007924234,0.00001141172,0.0001013306,1.364698e-7,0.0007443383,0.08372708,0.08051623,0.825183],"study_design_scores_gemma":[0.008624654,0.001917606,0.02511052,0.0003312248,0.0004165037,0.0000167576,0.003349804,0.0000151233,0.001172079,0.02679724,0.9316485,0.0005999645],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4785686,0.4493265,0.0001157135,0.03212627,0.01248923,0.005263609,0.0004212011,0.0003353489,0.02135351],"genre_scores_gemma":[0.8461861,0.1474113,0.001484973,0.0008622563,0.002813882,0.00007000288,0.00004471396,0.00007787873,0.001048899],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8511323,"threshold_uncertainty_score":0.9999622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}